Simplex Trading
NVNO

Simplex Trading’s enVVeno Medical NVNO Stock Holding History

Simplex Trading’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43
Closed -$481 – 9825
2025
Q4 		$481 Sell
43
-140
-77% -$2.72K ﹤0.01% 8163
2025
Q3 		$5K Sell
183
-420
-70% -$42.9K ﹤0.01% 8330
2025
Q2 		$84K Sell
603
-246
-29% -$29.1K ﹤0.01% 5412
2025
Q1 		$78K Buy
849
+283
+50% +$31.5K ﹤0.01% 5329
2024
Q4 		$59K Sell
566
-94
-14% -$10.5K ﹤0.01% 5707
2024
Q3 		$77K Sell
660
-1,051
-61% -$193K ﹤0.01% 5483
2024
Q2 		$314K Sell
1,711
-152
-8% -$26.5K ﹤0.01% 4172
2024
Q1 		$354K Buy
1,863
+1,280
+220% +$230K ﹤0.01% 4209
2023
Q4 		$104K Buy
583
+243
+71% +$38.7K ﹤0.01% 5351
2023
Q3 		$64K Buy
+340
New +$56.7K ﹤0.01% 5570
2023
Q2 		– Sell
-849
Closed -$138K – 9618
2023
Q1 		$138K Hold
849
– – ﹤0.01% 4779
2022
Q4 		$151K Sell
849
-1,431
-63% -$291K ﹤0.01% 4576
2022
Q3 		$501K Buy
2,280
+937
+70% +$199K ﹤0.01% 3469
2022
Q2 		$177K Sell
1,343
-488
-27% -$75.7K ﹤0.01% 4763
2022
Q1 		$408K Sell
1,831
-169
-8% -$32.8K ﹤0.01% 4112
2021
Q4 		$461K Buy
+2,000
New +$563K ﹤0.01% 3927

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Simplex Trading's NVNO Position: Q1 2026 in Review

Simplex Trading sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 2,659 shares — an estimated $29.9K sold.

Simplex Trading first reported a position in NVNO in Q3 2023 and held it in 5 quarters. The position peaked at $95K in Q3 2023. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Simplex Trading reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 2,659 enVVeno Medical shares in Q1 2026, an estimated $29.9K.
  • Simplex Trading first reported a position in enVVeno Medical in Q3 2023 and held it in 5 quarters.
  • Simplex Trading's enVVeno Medical position peaked at $95K in Q3 2023.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.